Global Assisted Reproductive Technology (ART) Market 鈥� In Vitro Fertilization, Artificial Insemination and Third Party Assisted ART Market Outlook 2022

The problem of infertility has aggravated globally with rise in advanced maternal age and various other factors. 鈥淕lobal Assisted Reproductive Technology (ART) Market 鈥� In Vitro Fertilization, Artificial Insemination and Third Party Assisted ART Market Outlook 2022鈥� provides an in-depth analysis of global Assisted Reproductive Technology (ART) market overall as well as major technologies such as In Vitro Fertilization, Artificial Insemination and Third-Party Assisted ART (Sperm donation, Egg donation, Embryo donation and Surrogates). Market outlook for overall Assisted Reproductive Technology (ART) market as well as aforementioned sub-segments has been provided for the period 2017-22.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global assisted reproductive technology market. The report has been segmented as following:-
Market Segmentation
鈥� In Vitro Fertilization
鈥� Artificial Insemination
鈥� Third-Party Assisted ART

Geographical Coverage
鈥� Global
鈥� Americas
鈥� Asia Pacific
鈥� Europe, Middle East & Africa

Companies Coverage
鈥� Merck & Co., Inc.
鈥� CooperSurgical, Inc.
鈥� Irvine Scientific Sales Company, Inc.
鈥� Vitrolife AB
鈥� Hamilton Thorne, Inc.,

Infertility is a medical condition characterized by inability to achieve pregnancy. The problem has aggravated in many parts of the world underscoring the need for technological prowess to address the issue. Advancement in medical technology has brought forth Assisted Reproductive Technology (ART) which is acting as saviour for treatment of infertility. ART procedures spans from Invitro Fertilization, Artificial Insemination technologies such as Intrauterine Insemination, Intravaginal Insemination and Intracervical Insemination to third party assisted ART. Adoption rate of ART techniques has been increasing at fast pace globally.

Growth of global Assisted Reproductive Technology (ART) market is primarily attributed to factors such as prevalence of infertility, advanced maternal age, high obesity rates, rising level of alcohol and tobacco consumption, low awareness of fertility problems and favourable reimbursement policies. However, the market faces challenges due to stringent regulatory norms and high treatment cost associated with treatment of infertility. The market is characterized by leading trends such growth in strategic alliances and technological advancement in various procedures pertaining to treatment of infertility using ART.
The report 鈥淕lobal Assisted Reproductive Technology (ART) Market 鈥� In Vitro Fertilization, Artificial Insemination and Third Party Assisted ART Market Outlook 2022鈥� provides in-depth analysis of the current scenario, detailed market outlook of the global Assisted Reproductive Technology (ART) market with coverage of major technologies such as In Vitro Fertilization, Artificial Insemination and Third-Party Assisted ART (Sperm donation, Egg donation, Embryo donation and Surrogates). Geographically, the market is segmented into Americas, Asia Pacific and Europe, Middle East & Africa. Future forecasts of ART market overall and across various sub-segments is provided in the report till the year 2022. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the global market include Merck & Co., Inc., CooperSurgical, Inc., Irvine Scientific Sales Company, Inc., Vitrolife AB, Hamilton Thorne, Inc., among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global assisted reproductive technology market.

Table Of Contents:

1. Executive Summary
2. Research Methodology
3. Assisted Reproductive Technology: Introduction
3.1 Infertility
3.1.1 Causes of Infertility
3.1.2 Infertility Treatments
3.2 Assisted Reproductive Technology (ART)
3.2.1 IVF
3.2.2 Assisted Insemination
3.2.3 Third Party Assisted ART
3.2.4 Assisted Reproductive Treatment (ART) Procedure
4. Assisted Reproductive Technology (ART) Market Analysis
4.1 Market Sizing
4.2 Market Share Analysis
4.2.1 Market Share by Technology
4.2.2 Market Share by Procedure
4.2.3 Market Share by Region
5. Assisted Reproductive Technology (ART) Market Segmentation
5.1 In Vitro Fertilization
5.1.1 Overview
5.1.2 IVF Procedure
5.1.3 Market Sizing (Actual & Forecasted)
5.1.4 Market Share by End-User
5.1.5 Market Penetration by Nations
5.2 Artificial Insemination Market
5.2.1 Overview
5.2.2 Artificial Insemination Procedure
5.2.3 Market Sizing (Actual & Forecasted)
5.2.4 Market Share by Procedure
5.2.5 Market Share by Region
5.3 Third-party assisted ART
5.3.1 Overview
6. Assisted Reproductive Technology (ART) Regional Analysis
6.1 Americas
6.1.1 Market Sizing (Actual & Forecasted)
6.1.2 The US
6.2 Asia Pacific
6.2.1 Market Sizing (Actual & Forecasted)
6.3 Europe Middle East & Africa (EMEA)
6.3.1 Market Sizing (Actual & Forecasted)
7. Assisted Reproductive Technology (ART) Market Dynamics
7.1 Industry Trends & Development
7.1.1 Strategic Alliances
7.1.2 Technological Advancement
7.2 Growth Drivers
7.2.1 Prevalence of Infertility
7.2.2 Advanced Maternal Age
7.2.3 High Obesity Rates
7.2.4 Rising Level of Tobacco & Alcohol Consumption
7.2.5 Low Awareness of Fertility Problems
7.2.6 Favorable Reimbursements
7.3 Challenges
7.3.1 Stringent Regulations
7.3.2 High Treatment Cost
8. Competitive Landscape
9. Company Profiles
9.1 Merck & Co., Inc.
9.2 CooperSurgical, Inc.
9.3 Irvine Scientific Sales Company, Inc.
9.4 Vitrolife AB
9.5 Hamilton Thorne, Inc.

List of Tables
Table 1: Major Causes of Infertility
Table 2: Typical Costs for ART Specific Treatments
Table 3: IVF Market Penetration by Nations
Table 4: Women鈥檚 Health and Fertility: Select M&A Transactions
Table 5: Obesity-Related Fertility Issues
Table 6: Assessment of Regulatory Landscape across Nations
Table 7: Assisted Reproductive Technology (ART) Players Financial Analysis (2017)
Table 8: The US Fertility Clinics Competitive Landscape

List of Figures
Figure 1: Rockville Research 鈥� Research Methodology
Figure 2: Infertility Causes by Patient Diagnosis
Table 1: Major Causes of Infertility
Table 2: Typical Costs for ART Specific Treatments
Figure 3: Assisted Reproductive Treatment (ART) Procedure
Figure 4: Global Assisted Reproductive Technology Market Size by Value, 2015-23E (US$ Billions)
Figure 5: Global Assisted Reproductive Technology Market Share by Technology (2016)
Figure 6: Global Assisted Reproductive Technology Market Share by Procedure (2016)
Figure 7: Global Assisted Reproductive Technology Market Share by Region (2016)
Figure 8: In Vitro Fertilization Procedure
Figure 9: Global In-Vitro Fertilization Market Sizing by Value, 2014-23E (US$ Billions)
Figure 10: Global In Vitro Fertilization (IVF) Market Share by End-User (2016)
Table 3: IVF Market Penetration by Nations
Figure 11: Artificial Insemination procedure
Figure 12: Global Artificial Insemination Market Size by Value, 2015-23E (US$ Billions)
Figure 13: Global Artificial Insemination Market Share by Type of Procedure (2016)
Figure 14: Global Artificial Insemination Market Share by Region (2016)
Figure 15: Americas Assisted Reproductive Technology (ART) Market Size by Value, 2015-23E (US$ Billions)
Figure 16: The US Assisted Reproductive Technology (ART) Market Size by Value, 2015-23E (US$ Billions)
Figure 17: U.S. Assisted Reproductive Technology Market Share by procedure, 2012-2023
Figure 18: Asia Pacific Assisted Reproductive Technology (ART) Market Size by Value, 2015-23E (US$ Billions)
Figure 19: EMEA Assisted Reproductive Technology (ART) Market Size by Value, 2015-23E (US$ Billions)
Table 4: Women鈥檚 Health and Fertility: Select M&A Transactions
Figure 20: Infertility Rates by Age (2015)
Figure 21: Leading 10 Countries with the Oldest First-time Mothers
Figure 22: Prevalence of Infertility in Couples actively attempting Reproduction (2014)
Table 5: Obesity-Related Fertility Issues
Table 6: Assessment of Regulatory Landscape across Nations
Table 7: Assisted Reproductive Technology (ART) Players Financial Analysis (2017)
Table 8: The US Fertility Clinics Competitive Landscape
Figure 23: Merck & Co., Inc. Revenue by Business Segment (FY2016)
Figure 24: Merck & Co., Inc. Net Sales, FY2012-FY2016 (US$ Billions)
Figure 25: The Cooper Companies Revenue by Business Segment (FY2016)
Figure 26: CooperSurgical, Inc. Net Sales, FY2012-FY2016 (US$ Billions)
Figure 27: Irvine Scientific Sales Company, Inc. Net Sales, FY2013-FY2016 (US$ Billions)
Figure 28: Vitrolife AB Revenue by Business Segment (FY2016)
Figure 29: Vitrolife AB Net Sales, FY2012-FY2016 (US$ Billions)
Figure 30: Hamilton Thorne, Inc. Revenue by Business Segment (FY2016)
Figure 31: Hamilton Thorne, Inc. Net Sales, FY2012-FY2016 (US$ Billions)
鈥�
Figure 1: Rockville Research 鈥� Research Methodology
Figure 2: Infertility Causes by Patient Diagnosis
Figure 3: Assisted Reproductive Treatment (ART) Procedure
Figure 4: Global Assisted Reproductive Technology Market Size by Value, 2015-23E (US$ Billions)
Figure 5: Global Assisted Reproductive Technology Market Share by Technology (2016)
Figure 6: Global Assisted Reproductive Technology Market Share by Procedure (2016)
Figure 7: Global Assisted Reproductive Technology Market Share by Region (2016)
Figure 8: In Vitro Fertilization Procedure
Figure 9: Global In-Vitro Fertilization Market Sizing by Value, 2014-23E (US$ Billions)
Figure 10: Global In Vitro Fertilization (IVF) Market Share by End-User (2016)
Figure 11: Artificial Insemination procedure
Figure 12: Global Artificial Insemination Market Size by Value, 2015-23E (US$ Billions)
Figure 13: Global Artificial Insemination Market Share by Type of Procedure (2016)
Figure 14: Global Artificial Insemination Market Share by Region (2016)
Figure 15: Americas Assisted Reproductive Technology (ART) Market Size by Value, 2015-23E (US$ Billions)
Figure 16: The US Assisted Reproductive Technology (ART) Market Size by Value, 2015-23E (US$ Billions)
Figure 17: U.S. Assisted Reproductive Technology Market Share by procedure, 2012-2023
Figure 18: Asia Pacific Assisted Reproductive Technology (ART) Market Size by Value, 2015-23E (US$ Billions)
Figure 19: EMEA Assisted Reproductive Technology (ART) Market Size by Value, 2015-23E (US$ Billions)
Figure 20: Infertility Rates by Age (2015)
Figure 21: Leading 10 Countries with the Oldest First-time Mothers
Figure 22: Prevalence of Infertility in Couples actively attempting Reproduction (2014)
Figure 23: Merck & Co., Inc. Revenue by Business Segment (FY2016)
Figure 24: Merck & Co., Inc. Net Sales, FY2012-FY2016 (US$ Billions)
Figure 25: The Cooper Companies Revenue by Business Segment (FY2016)
Figure 26: CooperSurgical, Inc. Net Sales, FY2012-FY2016 (US$ Billions)
Figure 27: Irvine Scientific Sales Company, Inc. Net Sales, FY2013-FY2016 (US$ Billions)
Figure 28: Vitrolife AB Revenue by Business Segment (FY2016)
Figure 29: Vitrolife AB Net Sales, FY2012-FY2016 (US$ Billions)
Figure 30: Hamilton Thorne, Inc. Revenue by Business Segment (FY2016)
Figure 31: Hamilton Thorne, Inc. Net Sales, FY2012-FY2016 (US$ Billions)

Companies Mentioned:

Merck & Co., Inc., CooperSurgical, Inc., Irvine Scientific Sales Company, Inc., Vitrolife AB, Hamilton Thorne, Inc.,

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂